Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

R-alpha-lipoic acid (R-ALA)

R-Alpha Lipoic Acid (R-ALA / Na-R-ALA) · also known as Natural alpha-lipoic acid, Stabilized sodium R-lipoate, Na-R-ALA

R-ALA is an antioxidant, but the free form taken as a supplement is not the same as the cofactor bound to mitochondrial enzymes. Direct free-radical scavenging and AMPK activation have been seen mainly in in-vitro and animal studies. Higher total glutathione has been measured in humans, but the specific pathway has not been confirmed.

Typical dose: Stabilized R-ALA 100–300 mg/day, taken on an empty stomach 30 minutes before a meal
Absorption and forms: The R form and the racemic mixture have different pharmacokinetic profiles, but there is currently no basis for a blanket claim that every clinical effect of the R form is markedly better than the racemic mixture. Free R-ALA readily polymerizes and loses activity when exposed to heat or acid, which gives the stabilized sodium R-lipoate (Na-R-ALA) a formulation advantage. Also, exogenous free lipoic acid is not the same as the cofactor already bound to mitochondrial enzymes.

Clinical uses and human evidence

Peripheral neuropathy (numbness and tingling)

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Baicus 2024 · Cochrane Database Syst Rev · Systematic review · n=816 — Alpha-lipoic acid for diabetic peripheral neuropathy
  2. Ziegler 2006 · Diabetes Care · RCT · n=181 — Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial

Body weight and body fat

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Bobe 2020 · J Nutr · RCT · n=81 — A Randomized Controlled Trial of Long-Term (R)-α-Lipoic Acid Supplementation Promotes Weight Loss in Overweight or Obese Adults without Altering Baseline Elevated Plasma Triglyceride Concentrations

High triglycerides

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Bobe 2020 · J Nutr · RCT · n=81 — A Randomized Controlled Trial of Long-Term (R)-α-Lipoic Acid Supplementation Promotes Weight Loss in Overweight or Obese Adults without Altering Baseline Elevated Plasma Triglyceride Concentrations

Blood sugar and insulin resistance

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Jibril 2022 · Endocr Connect · Meta-analysis · n=1035 — Efficacy and safety of oral alpha-lipoic acid supplementation for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized trials
  2. Luo 2025 · BMJ Open · Meta-analysis · n=704 — Alpha-lipoic acid on intermediate disease markers in overweight or obese adults: a systematic review and meta-analysis

All-cause mortality risk

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Ziegler 2011 · Diabetes Care · RCT · n=460 — Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial

Heart attack, stroke and other cardiovascular events

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Chen 2026 · JACC Heart Fail · RCT · n=300 — Efficacy of Alpha-Lipoic Acid in Patients With Ischemic Heart Failure: A Double-Blind, Randomized, Placebo-Controlled Study

Mechanisms of action

Nrf2/ARE activation of endogenous antioxidant enzymes

★★★☆☆Mechanism evidence: grade ASecondary target

In one human randomized controlled trial, R-ALA 600 mg/day raised HO-1 expression in peripheral blood mononuclear cells. That dose is higher than the 100–300 mg/day commonly used for this supplement, and there is currently no assurance that a lower dose would have the same effect.

References (1)
  1. Bobe 2020 · Human RCT: R-ALA 600 mg/day raised HO-1 expression in peripheral blood mononuclear cells

Substrate and cofactor supply for glutathione (GSH) synthesis

★★★☆☆Mechanism evidence: grade BSecondary target

In human trials, higher doses of racemic lipoic acid raised total blood glutathione, but the studies did not distinguish between synthesis, regeneration and transport. Cell studies show it can improve cystine utilization. The specific pathway has not been confirmed in humans, and the results should not be applied directly to usual doses of R-ALA.

References (2)
  1. Jariwalla 2008 · RCT in 33 people: racemic lipoic acid 900 mg/day raised total blood glutathione in people with HIV infection
  2. Han 1997 · Cell study: lipoic acid improved cystine utilization and increased intracellular GSH

AMPK sensing of cellular energy deficit and metabolic reprogramming

★★★☆☆Mechanism evidence: grade CSecondary target

Animal and cell studies show that lipoic acid can increase AMPK activity and glucose uptake in skeletal muscle, and the GLUT4 translocation findings also come mainly from animal and cell studies. Human results on blood sugar or insulin sensitivity cannot substitute for direct measurement of AMPK phosphorylation in tissue, and the size of the effect at usual doses is unclear.

References (1)
  1. Lee 2005 · Animal and cell studies: lipoic acid increased skeletal muscle AMPK activity and glucose uptake

Direct free radical trapping and chemical quenching

★★☆☆☆Mechanism evidence: grade DSecondary target

Lipoic acid and its reduced form, dihydrolipoic acid, are redox-active in vitro and can react with free radicals. In the body, however, free lipoic acid is present only briefly and has to compete with other antioxidant systems, so its contribution to direct free-radical scavenging in humans is hard to determine.

References (1)
  1. Hagen 2008 · Mechanism review: direct free-radical scavenging by lipoic acid in the body is limited by pharmacokinetics and competing reactions

Safety and drug interactions

R-ALA may mildly lower blood sugar, so people prone to low blood sugar should keep a light sugary snack on hand. The claim that long-term high-dose use calls for routine zinc and iron supplementation because of chelation lacks sufficient evidence. Insulin autoimmune syndrome (Hirata disease, which causes recurrent severe hypoglycemia) has been reported in East Asian people, particularly carriers of HLA-DRB1*04:06. If recurrent hypoglycemia occurs, stop taking it immediately and see a doctor.

Low blood sugar risk

Can improve insulin sensitivity. Reports link it to autoimmune hypoglycemia in East Asian people. Each of these may lower blood sugar. Taken together, especially on an empty stomach or alongside antidiabetic drugs, they may cause low blood sugar symptoms such as palpitations, shaking and cold sweats.

Open in the interactive app ›